baber/WOPTO huggingface dataset:
Patent NZ-586667-A (NZ)
Title: Vertical frame for scaffolding with horizontal arms welded to vertical supports via a perforated disk
Inventor: KRELLER HELMUT
IPC: E04G1/14
Filed: 2008-11-08
Abstract: A closed vertical frame (25.1) is disclosed for the construction of a scaffolding frame support. The frame comprises: (A) At least two parallel vertical supports (30.1, 30.2). (B) At least two parallel horizontal arms (35.1, 35.2) extending between the vertical supports (30.1, 30.2). (C) At least one stiffening diagonal rod (40.1) which is welded to two of the vertical supports or to two of the horizontal arms or to one vertical support and one horizontal arm. (D) Perforated disks (45.1-45.4) permanently fastened by welding in the upper or lower regions of the vertical supports. The perforated disks are arranged concentrically with respect to the vertical supports in flange-like manner. At least one of the horizontal arms (35.1, 35.2) is provided with a wedge shaped connecting head (50.1, 50.2) at each of its ends. The connecting heads (50.1, 50.2) are provided with a slit which engages with the perforated disk (45.1-45.4) and the connecting heads are welded to both the vertical supports (30.1, 30.2) and the perforated disks (45.1-45.4).
Patent NZ-590303-A (NZ)
Title: Method and system for saving power for electronic equipment wherein the user can alter the opportunities
Inventor: WEST WILLIAM B
IPC: G05D3/12
Filed: 2009-07-07
Abstract: 590303 Disclosed is a method and apparatus for presenting saving opportunities for electronic devices. The method includes receiving, by a controller, experience based data learned from past power behaviour of one or more devices; generating one or more power saving opportunities based on the experience based data; calculating estimated cost savings for the opportunities; presenting a notification message to a user that describes the power saving opportunities and associated cost savings for the opportunities; and permitting a user to alter one or more of the power saving opportunities.
Patent NZ-593540-A (NZ)
Title: Bracket with pairs of spaced apart openings to accommodate tie rods at a variety of separations
Inventor: KENNELLY BERNARD JOSEPH
IPC: E04B1/38
Filed: 2011-06-16
Abstract: 593540 A bracket for tie-down of a roof member which is supported by a structure. The bracket comprises a bearing portion and first and second pairs of openings (4, 6) which extend through the bracket, the openings of the second pair having a spacing which is greater than the spacing of the openings of the first pair, whereby the bracket can be mounted such that the bearing portion is received flat against the roof member and threaded upper ends of the rods are received through the openings of either the first pair or the second pair, according to the spacing of the rods, to receive threaded elements for effecting tight engagement between the bracket and rods and thus clamping of the roof member between the bearing portion and the structure to tie down the roof member. The bracket may be provided with a third pairs of openings (8) having a spacing which is greater than the spacing of the openings of the first pair or the second pair. The bracket may be configured as a plate. The bracket is used with packing (12) against which the threaded elements are receivable to effect the engagement between the bracket and rods, the packing being configured to bear against the threaded elements at varying angles such that the engagement and clamping can be effected with the bearing portion received flat against the roof member throughout a range of orientations of the roof member about a horizontal axis which extends perpendicular to a longitudinal axis of the roof member.
Patent NZ-593795-A (NZ)
Title: Pharmaceutical compositions comprising a hcv polymerase inhibitor prodrug
Inventor: CHATTERJI ASHISH
IPC: A61K31/513
Filed: 2010-01-11
Abstract: 593795 PHARMACEUTICAL COMPOSITIONS COMPRISING A HCV POLYMERASE INHIBITOR PRODRUG The present disclosure provides novel formulations of isobutyric acid (2R,3R,4R,5R)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-4-fluoro-2-isobutyryloxymethyl-4-methyl-tetrahydro-furan-3-yl ester) and hydroxypropylcellulose that provide high bulk density, low particle size better suited for improved compression and flow, good compression, and fast dissolution profiles.
Patent NZ-593956-A (NZ)
Title: Multiple stage blower with gas flow directed from first impeller to second impeller via annular chamber between inner and outer casings
Inventor: VIRR ALEXANDER
IPC: F04D17/12
Filed: 2004-06-10
Abstract: A blower has a motor 150 with opposed first and second shafts with respective first and second impellers fixed to the shafts. An inner casing supports the motor 150 and an outer casing supports the inner casing. An annular channel is provided between the inner and outer casings so that gas is directed from the first impeller to the second impeller via the annular chamber.
Patent NZ-596685-A (NZ)
Title: Novel pharmaceutically acceptable salts of 4-(1h-imidazol-4-ylmethyl)pyridine and their therapeutical uses
Inventor: CAPET MARC
IPC: A61P25/00
Filed: 2010-05-18
Abstract: The present invention concerns novel pharmaceutical compositions of immethridine, in particular of novel pharmaceutically acceptable salts thereof, such as the dioxalate salt of immethridine, as well as its therapeutical uses and novel process of preparation.
Patent NZ-596735-A (NZ)
Title: Recombinant production of peptides
Inventor: HUMMERICH DANIEL
IPC: A61K38/16
Filed: 2010-06-02
Abstract: Disclosed are repetitive self-assembling precursor proteins, nucleic acid sequences and expression constructs encoding the same and methods for recombinant production of peptides using such precursor proteins.
Patent NZ-599513-A (NZ)
Title: Compounds for the treatment of dyslipidemia and related diseases
Inventor: JAIN MUKUL R
IPC: A61K31/357
Filed: 2010-09-29
Abstract: ABSTRACT - 599513 The disclosure relates to compounds of the general formula (I), e.g. N-(benzyloxy)-2-methyl-5-((5-methyl-2-phenyloxazol-4-yl)methyl)-1,3-dioxane-2-carboxamide their tautomeric forms, their stereoisomers, regioisomers and their pharmaceutically acceptable salts, wherein the variables are as defined in the specification. These compounds are suitable for the treatment of dyslipidemia and related diseases.
Patent NZ-601359-A (NZ)
Title: Substituted benzoazole pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
Inventor: SINGH JASBIR
IPC: C07D263/58
Filed: 2008-11-20
Abstract: 601359 Disclosed are fused bicyclic compounds of either thiazole or oxazole with a six-membered ring of formula (I) where the substituents are as disclosed in the specification. Examples of compound of formula (I) include (R)-1-{ 5-[4-(3-chloro-phenyl)-2-methyl-benzothiazol-6-ylmethyl]-pyridin-2-yl} -azetidine-2-carboxylic acid hydrochloride; N-{ 4-[2-Amino-4-(3-chloro-phenyl)-benzooxazol-6-ylmethyl]-phenyl} -methanesulfonamide and 7-Benzo[1,3]dioxol-5-yl-5-(4-fluorobenzyl)-thiazolo[5,4-d]pyrimidin-2-ylamine. Also disclosed are pharmaceutical compositions comprising a compound of formula (I) and the use of a compound of formula (I) in the manufacture of a medicament for treating stroke, myocardial infarct, cardiovascular inflammatory conditions, cancer, asthma, COPD, bone loss, bladder inflammation, bladder over activity or pain arising from bladder inflammation.
Patent NZ-601533-A (NZ)
Title: Method of hydrothermal liquid phase sintering of ceramic materials and products derived therefrom
Inventor: RIMAN RICHARD E
IPC: C04B35/645
Filed: 2008-11-14
Abstract: A composition produced by a hydrothermal liquid phase sintering process, which process comprises allowing at least one component of a porous matrix to undergo a reaction with at least a first reactant carried by a liquid to provide at least a first product, during which reaction a remainder of the porous matrix acts as a scaffold for facilitating the formation of the at least first product from the liquid, thereby producing a hydrothermal liquid phase sintered composition, wherein the porous matrix comprises a metal oxide, metal hydroxide, metal sulfate, metal titanate, or a combination thereof, wherein the first product comprises carbonate, sulfate, oxalate, fluorophosphate, calcium, magnesium, strontium, titanium, zirconium, chromium, manganese, iron, nickel, copper, aluminium, or a mixture thereof, and wherein the hydrothermal liquid phase sintered composition substantially maintains the predetermined shape and size of the porous matrix, and wherein the first reactant comprises oxalate, carbonate, sulfate, fluorophosphates, metal ion, or a combination thereof.
Patent NZ-602080-A (NZ)
Title: Starter Motor for a Vehicle
Inventor: ATKINSON TRAVIS REID
IPC: F02N11/00
Filed: 2012-08-28
Abstract: A dual earth starter motor is disclosed for a vehicle. The starter motor includes a housing, an armature within the housing, a brush plate within the housing arranged to deliver electric current, by means of conductive brushes, to the armature, and two separate earth terminals electrically connected to the brush plate with each terminal extending through a wall of the housing. In a preferred form, the two earth terminals are electrically isolated from the housing, and at least one of the terminals is mechanically and electrically coupled to the brush plate my means of an interference fit between a portion of the terminal and a hole formed in the brush plate. Preferably that portion of the terminal has a knurled finish such that a plurality of contact points is formed between the terminal and the brush plate. A method of retrofitting a second earth terminal to an existing starter motor is also disclosed.
Patent NZ-614198-A (NZ)
Title: Antibodies that bind tgf-alpha and epiregulin
Inventor: BEIDLER CATHERINE BRAUTIGAM
IPC: C07K16/22
Filed: 2012-03-28
Abstract: Disclosed is an antibody that binds TGF-alpha and Epiregulin, comprising a light chain and a heavy chain, wherein the light chain variable region comprises LCDR1, LCDR2, and LCDR3, and the heavy chain variable region comprises amino acid sequences HCDR1, HCDR2, and HCDR3, wherein LCDR1 is RSSQSIVHSTGNTYLE, LCDR2 is KVSNRFS, LCDR3 is FHGTHVPYT, HCDR1 is GYTFTDAYIN, HCDR2 is WIWPGPVITYYNPKFKG, and HCDR3 is REVLSPFAY. Also disclosed is the use of such an antibody in the manufacture of a medicament for the treatment of diabetic nephropathy.
Patent NZ-615010-A (NZ)
Title: Detection of sleep onset
Inventor: ARMITSTEAD JEFFREY PETER
IPC: A61M16/00
Filed: 2010-07-14
Abstract: Disclosed is a method for detecting sleep onset. A set of respiratory features are determined from a measure of respiratory flow. These features are then thresholded and a sleep state score is determined based on the thresholding, which is indicative of a sleep state. Sleep onset is then determined as a function of the thresholding and the determined sleep state score.
Patent NZ-615953-A (NZ)
Title: Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives
Inventor: AJANI MAURO
IPC: C12P33/00
Filed: 2008-07-24
Abstract: The disclosure relates to an enzymatic esterification process for obtaining 17(-monoesters of cortexolone represented by formula (I) and its 9,11-dehydro derivatives starting from the corresponding 17(,21-diesters which comprises an enzymatic alcoholysis reaction in presence of a lipase from Candida. Furthermore, the disclosure relates to crystalline forms of cortexolone 17(-propionate to give cortexolone-17and 9,11-dehydro-cortexolone 17(-butanoate, for example by crystallizing said cortexolone-17(-propionate from a mixture of dichloromethane/n-hexane, or a mixture of acetone/n-hexane, or a mixture of ethanol/water, to get the crystalline form (III).
Patent NZ-619982-A (NZ)
Title: Tissue dispenser, method for dispensing tissue, and tissue dispenser insert
Inventor: ELLIOTT ADAM T
IPC: A47K10/38
Filed: 2012-07-25
Abstract: A tissue dispenser is disclosed. The tissue dispenser includes a housing (see 20, figure 1) for storing and dispensing two rolls of tissue, and a mandrel set constructed to move within the housing. The housing includes a first side wall (see 26, figure 3) and a cover constructed to provide an opening through which tissue can be dispensed, and a track (see 42, figure 3) extending along a portion of the first side wall. The mandrel set includes a first mandrel (48) constructed to hold a first roll of tissue (52), a second mandrel (49) constructed to hold a second roll of tissue (54), the first mandrel comprising a first recessed region. An arm extends from the first mandrel to the second mandrel. The arm includes a first pin and a second pin wherein the first pin and the second pin are constructed to engage and travel along the track. A stop (86) constructed integrally with the housing, to engage the first recessed region of the first mandrel to prevent the first madrel from by-passing the stop when the first roll of tissue is provided on the first mandrel. The tissue dispenser is constructed so that a roll of tissue on the first mandrel can be dispensed from the opening while the roll of tissue on the second mandrel is held in reserve, and once the roll of tissue on the first mandrel is depleted, the mandrel set can move along the track so that the roll of tissue on the second mandrel can be dispensed from the opening. A method of dispensing tissue, and a tissue dispenser insert for retrofitting a tissue dispenser are provided.
Patent NZ-623808-A (NZ)
Title: 7-{ (3s,4s)-3-[(cyclopropylamino)methyl]-4-fluoropyrrolidine-1-yl} -6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid crystal
Inventor: ARAYA ICHIRO
IPC: C07D401/04
Filed: 2012-11-09
Abstract: Disclosed herein are hydrochloride crystals, hydrochloride hydrate crystals, and methanesulfonate crystals of the compound represented by formula (1) (7-{ (3S,4S)-3-[(cyclopropylamino)methyl]-4-fluoropyrrolidine-1-y1} -6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid. These crystals are less susceptible to decomposition caused by the effects of light, and also have high preservation stability and high water solubility compared to a free crystal of the compound (1). Also disclosed are methods of producing the hydrochloride and methanesulfonate crystals.
Patent NZ-628239-A (NZ)
Title: Improvements in and relating to the calcination of rock material
Inventor: ROBERT HAMILTON HALL
IPC: C22B17/02
Filed: 2013-08-05
Abstract: Disclosed is an apparatus and methods of using said apparatus for the calcining treatment of reactive phosphate rock (RPR) and phosphate rock (PR) capable of producing a treated product with reduced cadmium levels suitable for the fertilisation of soil. The apparatus employs flash calcination to heat rock to temperatures higher than the boiling point of cadmium using flames and short residence times to effect rapid calcining that retains the reactivity of the phosphate rock.
Patent NZ-631497-A (NZ)
Title: Biocidal systems and methods of use
Inventor: ANGELA MARIE JOHNSON
IPC: C09K8/66
Filed: 2014-04-04
Abstract: Systems and methods for controlling microbial growth and/or activity in a gas field fluid or oil field fluid are provided, comprising: a) adding a first biocide component, such as glutaraldehyde, C12-16-alkyl dimethyl benzyl ammonium chloride (ADBAC quat), glutaraldehyde and ADBAC quat, tetrakis(hydroxymethyl) phosphonium sulfate, 2,2-dibromo- 3-nitrilopropionamide, [1,2-ethanediylbis(oxy)]bismethanol, 5-chloro-2- methyl-4-isothiazolin-3-one or chlorine dioxide and which is not dazomet to the gas field fluid or oil field fluid; and b) after a delay of about 1 minute to about 30 minutes, adding a second biocide component , which is 3,5-dimethyl-1,3,5-thiadiazinane-2-thione (dazomet) to the gas field fluid or oil field fluid; wherein the first biocide component and second biocide component are added in an amount effective to control microbial growth or activity.
Patent NZ-701450-A (NZ)
Title: Topical spray composition and system for delivering the same
Inventor: MORIKIS THOMAS NIKOLAOS
IPC: B65D83/62
Filed: 2013-04-24
Abstract: A topical spray composition and a system for containing and applying the composition is described. The composition has liquid emulsifiers that unexpectedly result in a superior product suitable to be applied homogeneously. The composition comprises: a) liquid emulsifier, the liquid emulsifier having an HLB from 3.0 to 7.0; and b) skin benefit agent. The composition is sprayable, has a viscosity from 500 to 4200 cps and a surface tension from 22 to 33 mN/m, and is substantially free of non-liquid emulsifier.
Patent NZ-705218-A (NZ)
Title: Production of soluble protein products from hemp (”h701”)
Inventor: GOSNELL BRANDY
IPC: A23L33/17
Filed: 2013-08-01
Abstract: A hemp protein product, which may be an isolate, produces solutions at low pH values and is useful for the fortification of soft drinks and sports drinks without precipitation of protein. The hemp protein product is obtained by extracting a hemp protein source material with an aqueous calcium salt solution to form an aqueous hemp protein solution, separating the aqueous hemp protein solution from residual hemp protein source, adjusting the pH of the aqueous hemp protein solution to a pH of about 1.5 to about 4.4 to produce an acidified hemp protein solution, which may be dried, following optional concentration and diafiltration, to provide the hemp protein product.
Patent NZ-705848-A (NZ)
Title: Anti-cd38 antibodies
Inventor: ELIAS KATHLEEN ANN
IPC: C07K16/28
Filed: 2011-12-30
Abstract: Disclosed is an isolated antibody which specifically binds human CD38 (SEQ ID NO: 1, as defined in the complete specification) and cynomolgus CD38 (SEQ ID NO: 2, as defined in the complete specification) comprising: a) a heavy chain variable region comprising: i) a first CDR comprising SEQ ID NO: 13 (GFTFNNYD); ii) a second CDR comprising SEQ ID NO: 14 (ISYDGSDK); iii) a third CDR comprising SEQ ID NO: 15 (ARVYYYGFSGPSMDV); and b) a light chain variable region comprising: i) a first CDR comprising SEQ ID NO: 16 (NSNIGSNT); ii) a second CDR comprising SEQ ID NO: 17 (SDS); iii) a third CDR comprising SEQ ID NO: 18 (QSYDSSLSGSR). Also disclosed is the use of said antibody in the manufacture of a medicament for the treatment of an auto immune disease.
Patent NZ-706242-A (NZ)
Title: Methods and compositions for diagnosis and prognosis of renal injury and renal failure
Inventor: ANDERBERG JOSEPH
IPC: G01N33/68
Filed: 2012-08-24
Abstract: Disclosed is a method for evaluating renal status in a subject ex vivo, comprising: performing one or more assays configured to detect one or more biomarkers in a body fluid sample obtained previously from the subject to provide an assay result, wherein at least one of the markers is Stromelysin-1:Metalloproteinase inhibitor 2 complex; and correlating an assay result(s) to the renal status of the subject.
Patent NZ-710850-A (NZ)
Title: Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
Inventor: LI DAVID
IPC: C07D403/12
Filed: 2014-03-05
Abstract: The invention relates to compounds of formula(I), or a pharmaceutically acceptable salt thereof: Formula (I) which possess inhibitory activity against activating mutant forms of EGFR, and are accordingly useful for their anti-cancer activity and in methods of treatment of the human or animal body. The invention also relates pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti- cancer effect in a warm-blooded animal such as man.
Patent NZ-717382-A (NZ)
Title: Wall panel installation
Inventor: WILLIAM JOHN TRICKETT
IPC: E04G21/16
Filed: 2016-02-24
Abstract: A partition wall includes soffit c channel sections; floor J channel sections which have one side wall higher than the other and at least one longitudinal upstanding rib in the base section; and lightweight autoclaved cement extrusion(ace) panels in which the panels incorporate a tongue in one end edge and a mating groove in the opposite end edge and a recess in at least one face of the panel adjacent the said tongue and groove to facilitate setting the panel joints. This invention addresses the problem of labour and lifting times and costs in installing walls in high rise buildings. The ACE panels are modified to provide a recess adjacent the tongue and groove joints of two end abutting panels. This recess accommodates the sealant joining compound to provide a paintable finished surface. The panels are installed into the soffit and floor channel tracks that require no other fastening apart from sealing. The floor and ceiling tracks are installed first. The floor tracks include at least one rib which supports the panels to allow them to be slid above the track fastening s and to absorb building movement and reduce stress on the panel joints.
Patent NZ-721650-A (NZ)
Title: [1,2,4]triazolo[1,5-a]pyrimidine derivatives as protozoan proteasome inhibitors for the treatment of parasitic diseases such as leishmaniasis
Inventor: BIGGART AGNES
IPC: A61P33/02
Filed: 2014-12-18
Abstract: The present invention provides compounds of Formula A: or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a parasite, such as leishmaniasis, human African trypanosomiasis and Chagas disease.
Patent NZ-727090-A (NZ)
Title: Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
Inventor: JANG MYUNG HYUN
IPC: C07K14/605
Filed: 2012-06-07
Abstract: Discloses a peptide comprising the amino acid sequence SEQ ID NO: 29; CA-AibQGTFTSDYSKYLDEKRAKEFVQWLMNTC
Patent NZ-730197-A (NZ)
Title: Bayesian causal relationship network models for healthcare diagnosis and treatment based on patient data
Inventor: NARAIN NIVEN
IPC: G06F17/00
Filed: 2015-09-11
Abstract: Systems, methods, and computer-readable medium are provided for healthcare analysis. Data corresponding to a plurality of patients is received. The data is parsed to generate normalized data for a plurality of variables, with normalized data generated for more than one variable for each patient. A causal relationship network model is generated relating the plurality of variables based on the generated normalized data using a Bayesian network algorithm. The causal relationship network model includes variables related to a plurality of medical conditions or medical drugs. In another aspect, a selection of a medical condition or drug is received. A sub-network is determined from a causal relationship network model. The sub-network includes one or more variables associated with the selected medical condition or drug. One or more predictors for the selected medical condition or drug are identified.
Patent NZ-734393-A (NZ)
Title: Magnetic removal or identification of damaged or compromised cells or cellular structures
Inventor: KRUG KRISTIE
IPC: B03C1/00
Filed: 2013-08-23
Abstract: A method for magnetic cellular manipulation, the method comprising: diluting a semen sample comprising sperm cells with a buffered media; contacting the diluted semen sample with a plurality of magnetic particles, each magnetic particle in the plurality of magnetic particles being no greater than 1000 nm in size and each magnetic particle comprising a negative zeta potential charge and a chargeable silicon-containing compound, the magnetic particles binding to the sperm cells solely through a zeta potential charge interaction; and manipulating the bound magnetic particles with a magnetic field.
Patent NZ-739130-A (NZ)
Title: Multivalent and multispecific gitr-binding fusion proteins
Inventor: TIMMER JOHN C
IPC: C07K16/28
Filed: 2016-07-22
Abstract: This disclosure generally provides molecules that specifically engage glucocorticoid-induced TNFR-related protein (GITR), a member of the TNF receptor superfamily (TNFRSF). More specifically, the disclosure relates to multivalent and/or multispecific molecules that bind at least GITR.